AJP Rep 2013; 03(01): 037-040
DOI: 10.1055/s-0032-1331378
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Second-Trimester Diagnosis of Triploidy: A Series of Four Cases

J. B. Wick
1   St. John's University, Collegeville, Minnesota
,
K. J. Johnson
2   Department of Medical Genetics, Mayo Clinic, Rochester, Minnesota
,
J. O'Brien
3   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota
,
M. J. Wick
4   Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota
5   Department of Medical Genetics, Mayo Clinic, Rochester, Minnesota
› Author Affiliations
Further Information

Publication History

07 July 2012

31 July 2012

Publication Date:
31 December 2012 (online)

Abstract

Triploidy occurs in 2 to 3% of conceptuses and accounts for approximately 20% of chromosomally abnormal first-trimester miscarriages. As such, triploidy is estimated to occur in 1 of 3,500 pregnancies at 12 weeks', 1 in 30,000 at 16 weeks', and 1 in 250,000 at 20 weeks' gestation. We present a series of four cases of second-trimester triploidy diagnosed at our center within a 1-year timeframe. This is remarkable, as the delivery volume at our institution is roughly 2,500/y. All patients were at least 19 weeks' gestation, with multiple abnormalities identified on prenatal ultrasound at 18 to 20 weeks' gestation; all fetuses had lethal anomalies, but anomalies were not consistent between cases. All patients elected for induction of labor before 24 weeks' gestational age. Two of the four cases had amniocentesis and chromosome analysis prior to delivery, and two cases had chromosome analysis performed on fetal tissue after delivery. All fetuses were examined following delivery. This case series demonstrates that the diagnosis of triploidy may not be obvious based on ultrasound and physical examination findings and highlights the importance of routine chromosome analysis on all prenatal diagnoses of multiple congenital anomalies prior to consideration of more complex genetic testing.

 
  • References

  • 1 McFadden DE, Langlois S. Parental and meiotic origin of triploidy in the embryonic and fetal periods. Clin Genet 2000; 58: 192-200
  • 2 McFadden DE, Kwong LC, Yam IY, Langlois S. Parental origin of triploidy in human fetuses: evidence for genomic imprinting. Hum Genet 1993; 92: 465-469
  • 3 Baumer A, Balmer D, Binkert F, Schinzel A. Parental origin and mechanisms of formation of triploidy: a study of 25 cases. Eur J Hum Genet 2000; 8: 911-917
  • 4 Gardner RJM, Sutherland GR, Schaffer LG. Chromosome Abnormalities and Genetic Counseling. 4th ed. New York, NY: Oxford University Press; 2012
  • 5 Daniel A, Wu Z, Bennetts B , et al. Karyotype, phenotype and parental origin in 19 cases of triploidy. Prenat Diagn 2001; 21: 1034-1048
  • 6 McFadden DE, Kalousek DK. Two different phenotypes of fetuses with chromosomal triploidy: correlation with parental origin of the extra haploid set. Am J Med Genet 1991; 38: 535-538
  • 7 Doshi N, Surti U, Szulman AE. Morphologic anomalies in triploid liveborn fetuses. Hum Pathol 1983; 14: 716-723
  • 8 McFadden DE, Robinson WP. Phenotype of triploid embryos. J Med Genet 2006; 43: 609-612
  • 9 Lapaire O, Lu XY, Johnson KL , et al. Array-CGH analysis of cell-free fetal DNA in 10 mL of amniotic fluid supernatant. Prenat Diagn 2007; 27: 616-621
  • 10 Chiu RW, Lo YM. Noninvasive prenatal diagnosis empowered by high-throughput sequencing. Prenat Diagn 2012; 32: 401-406